RecruitingNCT04848844

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R): A Global Register to Investigate Factors Associated With Morbidity and Mortality in Adult Patients With Congenital Heart Disease (ACHD) on the Waiting List for Heart or Heart/Lung Transplantation


Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

2,000 participants

Start Date

Sep 2, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the surgical success, the morbidity and mortality of ACHD is higher than in the general population and is linked to the development of heart failure (HF) in adulthood. HF occurs in approximately 25% of patients with ACHD, even in those patients in whom the congenital mal-formation has been corrected successfully in childhood. The time course and presentation are heterogeneous owing to variable congenital malformation and limitation of treatment options. ACHD with an anatomic right ventricle as the systemic ventricle (e.g., atrial switch operation in patients with transposition of the great arteries \[TGAs\]) and those with a functional single ventricle (e.g., Fontan circulation) appear to be at higher risk of developing HF. Young age at initial corrective surgery-often in the first 2 years of life-and lack of specific medical therapies can contribute to a high and early demand for heart transplantation in patients with ACHD.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an international registry (database) collecting data from adult patients with congenital heart disease or inherited heart muscle conditions who are being considered for or listed for a heart transplant. The goal is to track outcomes and improve care for this complex group of patients. **You may be eligible if:** - You are an adult (18 or older) being evaluated for or listed for a heart transplant - You have a congenital heart defect (a heart condition present from birth) or an inherited cardiomyopathy (such as hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, or non-compaction cardiomyopathy) - This is your first time being listed for a heart (or combined heart-organ) transplant **You may NOT be eligible if:** - You are being listed for a second heart transplant (re-transplantation) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Heart and Vascular Center Hamburg

Hamburg, Free and Hanseatic City of Hamburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04848844


Related Trials